Apogee Share Price

Apogee Share Price

NASDAQ: APGE | Healthcare
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Apogee Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Apogee Share Price Chart

$0.00$0.00
L
Show Current Price
H

Apogee Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.89
Revenue (TTM)
$0.00
Return On Equity (TTM)
-24.64%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-32.04%

Apogee Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$65.02-$69.39-$74.11-$85.85
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-6.72%-6.80%-15.84%

Apogee Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$83.99-$182.15-$255.84
Net Profit MarginN/AN/AN/A
Income ChangeN/A-116.87%-40.46%

Apogee Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets195.78224.243.0
Current Assets741.36529.71398.41
Total Assets937.13753.95401.4
Non Current Liabilities5.358.60.93
Current Liabilities27.9128.5620.56
Total Liabilities33.2537.1621.49
Shareholders' Equity903.88716.79379.91

Apogee Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-227.45-171.17-74.76
Investing-179.57-300.46-273.91
Financing396.49495.11315.39

About Apogee

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Apogee Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

Apogee Share Price FAQs